TriSalus Life Sciences Income Statement (2020-2026) | TLSI

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
3.92M3.23M2.98M4.61M5.19M5.72M6.46M7.36M7.35M8.26M9.17M11.21M11.57M13.21M8.90M
Cost of Revenue (Quarter)
0.70M0.82M0.66M0.77M0.59M0.58M0.97M0.91M1.00M1.22M1.50M1.80M1.91M1.76M1.23M
Gross Profit (Quarter)
3.22M2.41M2.32M3.84M4.60M5.14M5.49M6.45M6.34M7.04M7.67M9.41M9.66M11.44M7.67M
Operating items
Research & Development (Quarter)
3.03M12.48M5.64M3.49M9.51M7.77M5.84M6.00M4.22M11.11M6.73M3.92M6.84M-5.77M7.41M
Selling, General & Administrative (Quarter)
0.78M0.81M1.14M0.67M0.29M3.50M4.06M3.55M4.90M9.03M6.01M4.63M3.96M4.73M4.66M5.25M5.66M6.66M4.17M5.45M
Operating Expenses (Quarter)
0.78M0.81M1.14M0.67M0.29M6.53M16.54M9.19M8.39M18.53M13.78M10.47M9.96M8.95M15.77M11.98M9.58M13.50M-1.60M12.86M
Operating Income (Quarter)
-0.78M-0.81M-1.14M-0.67M-0.29M-8.11M-11.77M-10.12M-11.43M-18.62M-14.25M-11.67M-8.17M-8.74M-7.58M-7.33M-7.33M-9.01M-3.27M-8.41M
EBIT (Quarter)
-0.78M-0.81M-1.14M-0.67M-0.29M-8.11M-11.77M-10.12M-11.43M-18.62M-14.25M-11.67M-8.17M-8.74M-7.58M-7.33M-7.33M-9.01M-3.27M-8.41M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.02M0.01M0.06M0.31M0.05M0.10M0.04M0.04M0.12M0.24M0.09M0.10M0.16M0.06M0.07M0.13M0.17M0.18M0.16M
Other Non Operating Income (Quarter)
-0.03M-2.12M0.88M-3.42M0.02M-0.15M-0.04M-0.01M-0.10M-0.25M-0.04M-0.09M-0.07M-0.08M
Non Operating Income (Quarter)
1.16M2.67M4.04M3.51M2.70M1.28M1.36M0.42M0.48M
Net income details
EBT (Quarter)
0.38M1.86M2.90M2.84M2.41M-8.09M-22.54M-8.27M-13.96M-1.43M-35.64M-13.20M-4.33M-2.40M-10.11M-10.37M-8.29M-10.81M-9.75M1.54M
Tax Provisions (Quarter)
0.03M0.01M-0.01M0.01M0.00M0.00M0.01M-0.00M-0.00M0.01M-0.00M0.01M0.00M
Profit After Tax (Quarter)
0.38M1.86M2.90M-7.87M-8.68M-8.09M-22.54M-8.31M-13.98M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M-9.75M1.54M
Income from Continuing Operations (Quarter)
0.38M1.86M2.90M2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M-9.75M1.54M
Consolidated Net Income (Quarter)
0.38M1.86M2.90M2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M-9.75M1.54M
Income towards Parent Company (Quarter)
0.38M1.86M2.90M2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M-9.75M1.54M
Preferred Dividend Payments (Quarter)
0.46M0.80M0.80M0.80M0.78M0.71M0.71M18.52M11.95M
Net Income towards Common Stockholders (Quarter)
0.08M0.37M-0.54M2.27M1.91M-8.09M-25.37M-9.23M-16.00M-1.88M-36.44M-14.01M-5.13M-3.20M-10.89M-11.09M-9.00M-41.27M-9.75M1.54M
Additional items
EPS (Basic) (Quarter)
-25.95-81.95-0.57-35.84-0.14-3.88-0.60-0.21-0.12-0.43-0.39-0.27-0.96-0.260.03
EPS (Diluted) (Quarter)
-25.95-81.95-0.57-35.84-0.14-3.88-0.60-0.21-0.12-0.43-0.39-0.27-0.96-0.260.03
Shares Outstanding (Quarter)
0.31M0.31M16.17M0.45M13.17M9.40M23.32M23.90M26.50M25.33M28.53M32.90M43.06M37.90M51.54M
Shares Outstanding (Diluted) (Quarter)
0.31M0.31M16.17M0.45M13.17M9.40M23.32M23.90M26.50M25.33M28.53M32.90M43.06M37.90M52.31M
EBITDA (Quarter)
-0.78M-0.81M-1.14M-0.67M-0.29M-8.11M-11.77M-10.12M-11.43M-18.62M-14.25M-11.67M-8.17M-8.74M-7.58M-7.33M-7.33M-9.01M-3.27M-8.41M
Interest Expenses (Quarter)
0.65M0.43M0.01M0.00M0.00M0.01M0.05M0.45M1.14M-0.01M1.21M1.50M1.50M3.02M1.44M
Tax Rate (Quarter)
1.17%-0.03%0.06%-0.09%0.00%-0.02%-0.16%0.12%0.01%-0.05%0.04%-0.05%0.26%